abiraterone acetate

Generic: abiraterone acetate

Labeler: florida pharmaceutical products, llc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name abiraterone acetate
Generic Name abiraterone acetate
Labeler florida pharmaceutical products, llc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

abiraterone acetate 250 mg/1

Manufacturer
Florida Pharmaceutical Products, LLC.

Identifiers & Regulatory

Product NDC 71921-178
Product ID 71921-178_38b4b689-c306-42a0-9df6-5b125314aaab
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212462
Listing Expiration 2026-12-31
Marketing Start 2022-08-15

Pharmacologic Class

Classes
cytochrome p450 17a1 inhibitor [epc] cytochrome p450 17a1 inhibitors [moa] cytochrome p450 2c8 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71921178
Hyphenated Format 71921-178

Supplemental Identifiers

RxCUI
1100075
UPC
0371921178209
UNII
EM5OCB9YJ6

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name abiraterone acetate (source: ndc)
Generic Name abiraterone acetate (source: ndc)
Application Number ANDA212462 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (71921-178-20)
source: ndc

Packages (1)

Ingredients (1)

abiraterone acetate (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "38b4b689-c306-42a0-9df6-5b125314aaab", "openfda": {"upc": ["0371921178209"], "unii": ["EM5OCB9YJ6"], "rxcui": ["1100075"], "spl_set_id": ["b3e7f851-4132-4003-8f14-0eea21e5009c"], "manufacturer_name": ["Florida Pharmaceutical Products, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (71921-178-20)", "package_ndc": "71921-178-20", "marketing_start_date": "20220815"}], "brand_name": "abiraterone acetate", "product_id": "71921-178_38b4b689-c306-42a0-9df6-5b125314aaab", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 17A1 Inhibitor [EPC]", "Cytochrome P450 17A1 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "product_ndc": "71921-178", "generic_name": "abiraterone acetate", "labeler_name": "Florida Pharmaceutical Products, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "abiraterone acetate", "active_ingredients": [{"name": "ABIRATERONE ACETATE", "strength": "250 mg/1"}], "application_number": "ANDA212462", "marketing_category": "ANDA", "marketing_start_date": "20220815", "listing_expiration_date": "20261231"}